Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AML.

Leukemia - 1 Apr 2020

Ren Zhuo, Shrestha Mariusz, Sakamoto Takashi, Melkman Tali, Meng Li, Cairns Rob A, Zacksenhaus Eldad, Mak Tak W, Stambolic Vuk, Minden Mark D, Wang Jiance Atom

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Leukemia, Myeloid, Acute
Share to Mutation
Share to Nuclear Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nucleophosmin

Share to Phosphorylation

Share to Proto-Oncogene Proteins c-akt

Share to Signal Transduction

Source

Identifiers

PMID: 31728055
DOI: 10.1038/s41375-019-0621-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Opposing effects of NPM1wt and NPM1c mutants on AKT signaling in AML.PMID 31728055Read ↗

The antagonistic duality of NPM1 mutations in AML.Semantic proximity Read ↗

Biological and clinical consequences of NPM1 mutations in AML.Semantic proximity Read ↗

A scale of "bad" co-mutations in NPM1-driven AML.Semantic proximity Read ↗

Targeted therapy in NPM1-mutated AML: Knowns and unknownsSemantic proximity Read ↗

NPM1-mutated AML: how many diseases?Semantic proximity Read ↗

When the good go bad: Mutant NPM1 in acute myeloid leukemia.Semantic proximity Read ↗

MiR-10a-5p regulates proliferation, apoptosis and cell cycle of NPM1-mutated acute myeloid leukemia cells by targeting SHANK3Semantic proximity Read ↗

Recent advances in AML with mutated NPM1.Semantic proximity Read ↗

MN1, a novel player in human AMLSemantic proximity Read ↗

Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group.Semantic proximity Read ↗

New strategies to treat AML: novel insights into AML survival pathways and combination therapiesSemantic proximity Read ↗

PLA2G4A Is a Potential Biomarker Predicting Shorter Overall Survival in Patients with Non-M3/ NPM1 Wildtype Acute Myeloid LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.